OCULAR THERAPEUTIX INC (OCUL) Stock Income Statement
NASDAQ:OCUL - Nasdaq - US67576A1007 - Common Stock - Currency: USD
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 56.66M | 63.72M | 58.44M | 51.49M | 43.52M | |||
| Cost Of Goods | 6.00M | 5.63M | 5.28M | 4.54M | 4.41M | |||
| Gross Profit | 50.67M | 58.10M | 53.16M | 46.95M | 39.12M | |||
| Operating Expenses | 278.80M | 229.88M | 135.54M | 125.61M | 117.15M | |||
| Research and Development | 171.98M | 127.64M | 61.05M | 53.46M | 50.08M | |||
| Selling, General, and Administrative Expenses | 106.82M | 102.24M | 74.49M | 72.15M | 67.07M | |||
| Operating Income | -228.13M | -171.78M | -82.38M | -78.65M | -78.04M | |||
| Interest Income/Expense | 11.36M | 6.22M | -12.54M | 7.62M | 71.48M | |||
| Other Income/Expense | N/A | N/A | -1.00K | 0.00 | 0.00 | |||
| Non Recurring Items | N/A | -27.95M | 14.19M | N/A | N/A | |||
| Income Before Taxes | -216.75M | -193.51M | -80.74M | -71.04M | -6.55M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -216.75M | -193.51M | -80.74M | -71.04M | -6.55M | |||
| EBITDA | -224.22M | -168.00M | -79.40M | -76.54M | -75.62M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.28 | -1.22 | -1.01 | -0.92 | -0.09 | |||
| Non GAAP EPS | -1.28 | -1.47 | -1.17 | -0.96 | -0.09 | |||
| Statistics | ||||||||
| Gross Profit Margin | 89.42% | 91.17% | 90.96% | 91.18% | 89.89% | |||
| Profit Margin | -382.51% | -303.67% | -138.14% | -137.97% | -15.05% | |||
| Operating Profit Margin | -402.60% | -269.57% | -140.96% | -152.75% | -179.32% | |||
All data in USD